Vimarsana
Biggest News Aggregation in the World

Liver Dis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liver Dis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liver Dis Today - Breaking & Trending Today

Iron supplementation with high tolerability for celiac disease - Vimarsana News

Iron supplementation with high tolerability for celiac disease

Celiac disease is a chronic autoimmune disease that affects the small intestine. While iron supplementation is often required for patients with celiac disease, this can come with side effects. Could a new innovative technology be the answer?

Implausible algorithm output in UK liver transplantation allocation scheme: importance of transparency - Vimarsana News

Implausible algorithm output in UK liver transplantation allocation scheme: importance of transparency

Algorithm-based allocation of resource-limited health-care interventions is growing; however, concerns over transparency and bias have restricted its use.1 Transparent algorithms can be readily explained, allowing patients and clinicians to clearly understand the basis for decision making.2 In 2018, the Transplant Benefit Score (TBS) was introduced to allocate deceased donor livers to patients with chronic liver disease and primary liver cancer (hepatocellular carcinoma) on a national basis. Patients might also undergo transplantation for acute liver failure, although these patients are alloca...

Hepatitis B - Vimarsana News

Hepatitis B

Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis B core antibody (IgM anti-HBc, for the window period when neither HBsAg nor anti-HBs is detected). Assessment of HBV replication status to guide treatment decisions involves testing for HBV DNA, whereas assessment of liver disease activity and staging is mainly based on aminotransferases, platelet count, a...

Global Liver Institute Releases Comprehensive U.S. NASH Action Plan - Vimarsana News

Global Liver Institute Releases Comprehensive U.S. NASH Action Plan

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Global Liver Institute Releases Comprehensive U.S. NASH Action Plan Global Liver InstituteFebruary 9, 2021 GMT Washington, DC, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) and the GLI NASH Council have released the U.S. NASH Action Plan to comprehensively address nonalcoholic steatohepatitis (NASH), the advanced form of nonalcoholic fatty liver disease (NAFLD), and its impact on patients and families, public health, and the economy. It is estimated that up to 40 million people in t...

Source: apnews.com